State Of Alaska, Department Of Revenue Regeneron Pharmaceuticals, Inc. Transaction History

State Of Alaska, Department Of Revenue

  • $9.42 Billion
  • Q3 2024

A detailed history of State Of Alaska, Department Of Revenue transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 19,294 shares of REGN stock, worth $13.8 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
19,294
Previous 20,799 7.24%
Holding current value
$13.8 Million
Previous $21.9 Million 7.21%
% of portfolio
0.22%
Previous 0.25%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024
SELL
$1024.09 - $1201.76 $1.54 Million - $1.81 Million
-1,505 Reduced 7.24%
19,294 $20.3 Million
Q2 2024

Aug 05, 2024
SELL
$883.2 - $1071.19 $388,608 - $471,323
-440 Reduced 2.07%
20,799 $21.9 Million
Q1 2024

Apr 19, 2024
SELL
$902.69 - $993.35 $1.71 Million - $1.88 Million
-1,895 Reduced 8.19%
21,239 $20.4 Million
Q4 2023

Jan 19, 2024
SELL
$775.18 - $881.7 $162,787 - $185,157
-210 Reduced 0.9%
23,134 $20.3 Million
Q3 2023

Oct 16, 2023
SELL
$692.45 - $844.37 $477,790 - $582,615
-690 Reduced 2.87%
23,344 $19.2 Million
Q2 2023

Jul 24, 2023
SELL
$700.03 - $830.35 $8.25 Million - $9.78 Million
-11,780 Reduced 32.89%
24,034 $17.3 Million
Q1 2023

Apr 17, 2023
SELL
$680.49 - $826.97 $129,973 - $157,951
-191 Reduced 0.53%
35,814 $29.4 Million
Q4 2022

Jan 11, 2023
BUY
$705.89 - $766.39 $3.01 Million - $3.27 Million
4,267 Added 13.44%
36,005 $26 Million
Q3 2022

Oct 20, 2022
SELL
$573.97 - $724.32 $7.38 Million - $9.32 Million
-12,864 Reduced 28.84%
31,738 $21.9 Million
Q2 2022

Jul 08, 2022
BUY
$548.35 - $738.84 $9.95 Million - $13.4 Million
18,137 Added 68.53%
44,602 $26.4 Million
Q1 2022

Apr 14, 2022
BUY
$595.12 - $698.43 $2.13 Million - $2.5 Million
3,575 Added 15.62%
26,465 $18.5 Million
Q4 2021

Jan 12, 2022
BUY
$543.48 - $670.97 $2.54 Million - $3.13 Million
4,669 Added 25.62%
22,890 $14.5 Million
Q3 2021

Oct 07, 2021
BUY
$574.03 - $680.96 $115,954 - $137,553
202 Added 1.12%
18,221 $11 Million
Q2 2021

Jul 12, 2021
SELL
$472.8 - $558.54 $4.69 Million - $5.54 Million
-9,911 Reduced 35.49%
18,019 $10.1 Million
Q1 2021

Apr 09, 2021
SELL
$446.73 - $548.2 $613,807 - $753,226
-1,374 Reduced 4.69%
27,930 $13.2 Million
Q4 2020

Jan 08, 2021
SELL
$478.3 - $607.98 $650,009 - $826,244
-1,359 Reduced 4.43%
29,304 $14.2 Million
Q3 2020

Oct 05, 2020
SELL
$544.75 - $658.21 $3.09 Million - $3.74 Million
-5,681 Reduced 15.63%
30,663 $17.2 Million
Q2 2020

Jul 06, 2020
BUY
$493.32 - $643.92 $11.2 Million - $14.6 Million
22,607 Added 164.57%
36,344 $22.7 Million
Q1 2020

Apr 06, 2020
BUY
$336.18 - $494.43 $203,388 - $299,130
605 Added 4.61%
13,737 $6.71 Million
Q4 2019

Jan 07, 2020
SELL
$274.13 - $376.51 $298,801 - $410,395
-1,090 Reduced 7.66%
13,132 $4.93 Million
Q3 2019

Oct 02, 2019
BUY
$273.46 - $318.39 $394,876 - $459,755
1,444 Added 11.3%
14,222 $3.95 Million
Q2 2019

Jul 23, 2019
SELL
$299.6 - $414.82 $94,973 - $131,497
-317 Reduced 2.42%
12,778 $4 Million
Q1 2019

Apr 09, 2019
SELL
$372.08 - $439.57 $91,531 - $108,134
-246 Reduced 1.84%
13,095 $5.38 Million
Q4 2018

Jan 10, 2019
SELL
$335.82 - $403.04 $24,514 - $29,421
-73 Reduced 0.54%
13,341 $4.98 Million
Q3 2018

Oct 09, 2018
SELL
$351.14 - $408.51 $114,471 - $133,174
-326 Reduced 2.37%
13,414 $5.42 Million
Q2 2018

Jul 10, 2018
BUY
$284.6 - $344.99 $754,190 - $914,223
2,650 Added 23.9%
13,740 $4.74 Million
Q1 2018

Apr 19, 2018
BUY
$315.82 - $393.78 $562,159 - $700,928
1,780 Added 19.12%
11,090 $3.82 Million
Q4 2017

Jan 19, 2018
BUY
$358.63 - $469.95 $2.89 Million - $3.78 Million
8,050 Added 638.89%
9,310 $3.5 Million
Q3 2017

Oct 16, 2017
BUY
$431.38 - $504.0 $543,538 - $635,040
1,260
1,260 $563,000

Others Institutions Holding REGN

# of Institutions
1,535
Shares Held
83.8M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track State Of Alaska, Department Of Revenue Portfolio

Follow State Of Alaska, Department Of Revenue and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email